Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients

Malignant Neoplasm Clinical Trial

Official title:

The Patient Cancer OUtreach, Navigation, Technology, and Support (Patient COUNTS) Project: Addressing Care for Asian Americans With Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03867916
• Other study ID #: 184511
• Secondary ID: NCI-2018-02196
• Status: Completed
• Phase: N/A
• Start date: December 13, 2018
• Est. completion date: December 31, 2022

Study information

• Verified date: January 2023
• Source: University of California, San Francisco
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve the care provided to Asian American cancer patients.This study is offered in the following languages in addition to English: Chinese (Cantonese or Mandarin) and Vietnamese.

Description:

PRIMARY OBJECTIVES:

I. Identify Asian American adults newly diagnosed with colorectal, liver, or lung cancer using a population-based cancer registry.

II. Conduct outreach to these patients to let them know about the availability of information on these cancers, the Patient Cancer OUtreach, Navigation, Technology and Support (COUNTS) web portal, and the Patient COUNTS patient navigation program.

III. Provide patient navigation either virtually or in-person.

OUTLINE:

Patients attend focus groups to help develop patient portal and navigation program. Patients use in-person navigation program. In phase II, patients use an online portal to access navigation program and may choose to have online/virtual navigation support or in-person navigation support. Patients also complete data collection and surveys over 15 minutes via web portal at baseline, 3 months, and 6 months and user experience survey at end of program participation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 106
• Est. completion date: December 31, 2022
• Est. primary completion date: November 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• FOR INTERVIEWS AND FOCUS GROUPS:

• Cancer patients: Self-identifies as Asian American, lives in San Francisco, speaks English, Mandarin, Cantonese, or Vietnamese, has a history of cancer of any kind

• Caregivers: any person age 21 and older who has provided care to an Asian American cancer patient

• Health professionals: physicians and other health professionals age 21 and older who provide care to Asian American patients with cancer

• FOR PILOT IMPLEMENTATION:

• Self-identifies as Asian American

• Ages 21 or older

• Lives in the 9 counties of the greater bay area cancer registry (GBACR)

• Speaks English, Mandarin, Cantonese, or Vietnamese

• Has any stage colorectal, lung, or liver cancer

• Has not started treatment or has not completed treatment

• Is willing to stay in the study for six months.

• FOR FULL IMPLEMENTATION:

• Self-identifies as Asian American

• Ages 21 or older

• Lives in the 9 counties of the GBACR

• Speaks English, Mandarin, Cantonese, or Vietnamese

• Has any stage colorectal, lung, or liver cancer,

• Has not started or has not completed treatment

• Is willing to stay in the study for six-seven months

Exclusion Criteria:

*Any medical or psychological conditions precluding informed consent

Related Conditions & MeSH terms

• Caregiver
• Colorectal Neoplasms
• Liver Neoplasms
• Lung Neoplasms
• Malignant Neoplasm
• Neoplasms
• Physician
• Stage I Colorectal Cancer AJCC v8
• Stage I Liver Cancer
• Stage I Lung Cancer AJCC v8
• Stage IA1 Lung Cancer AJCC v8
• Stage IA2 Lung Cancer AJCC v8
• Stage IA3 Lung Cancer AJCC v8
• Stage IB Lung Cancer AJCC v8
• Stage II Colorectal Cancer AJCC v8
• Stage II Liver Cancer
• Stage II Lung Cancer AJCC v8
• Stage IIA Colorectal Cancer AJCC v8
• Stage IIA Lung Cancer AJCC v8
• Stage IIB Colorectal Cancer AJCC v8
• Stage IIB Lung Cancer AJCC v8
• Stage IIC Colorectal Cancer AJCC v8
• Stage III Colorectal Cancer AJCC v8
• Stage III Liver Cancer
• Stage III Lung Cancer AJCC v8
• Stage IIIA Colorectal Cancer AJCC v8
• Stage IIIA Lung Cancer AJCC v8
• Stage IIIB Colorectal Cancer AJCC v8
• Stage IIIB Lung Cancer AJCC v8
• Stage IIIC Colorectal Cancer AJCC v8
• Stage IIIC Lung Cancer AJCC v8

Intervention

Behavioral:
• Patient Navigation Program
Use patient navigation program

Other:
• Quality-of-Life Assessment
Ancillary studies
• Survey Administration
Ancillary studies

Locations

Country	Name	City	State
United States	University of California, San Francisco	San Francisco	California

Sponsors (2)

Lead Sponsor	Collaborator
University of California, San Francisco	Bristol-Myers Squibb Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of Participation	At least one contact with patient navigator	Any time between consent and month 6
Secondary	Adherence to Guideline Treatment	Positive response(s) to survey item(s) on completion of MD-recommended treatment	Month 6
Secondary	Patient Acceptability	Response of "satisfied" or "very satisfied" to survey item on satisfaction with Patient COUNTS navigation program	Month 7